Division of General Thoracic Surgery, Department of Surgery, Shinshu University School of Medicine, Matsumoto, Japan.
Division of General Thoracic Surgery, Department of Surgery, Shinshu University School of Medicine, Matsumoto, Japan.
Ann Thorac Surg. 2022 Jul;114(1):257-264. doi: 10.1016/j.athoracsur.2021.07.019. Epub 2021 Aug 10.
The necessity of thoracic epidural analgesia (TEA) during minimally invasive surgery (MIS) remains unclear. We investigated TEA efficacy in MIS versus thoracotomy and the noninferiority of a preemptive intercostal nerve block (ICNB) to TEA in MIS.
We investigated 393 patients who underwent lung resection, with and without TEA, between 2014 and 2019 (242 MIS, 151 thoracotomy) and 93 patients who underwent MIS with ICNB between 2019 and 2020. To address selection bias 70 TEA and 70 ICNB patients were propensity score matched. Endpoints were pain score during hospitalization, postoperative complications, duration of operating room use, analgesia-related adverse effects, and use of supplemental pain medication.
One-third of patients with MIS discontinued TEA on postoperative day 1 or earlier; those with early TEA discontinuation reported worse pain the next day. TEA was associated with lower pain scores compared with non-TEA, regardless of surgical invasiveness, and a lower complication risk in patients with thoracotomy but not MIS. For MIS, ICNB was associated with an equivalent pain score on postoperative day 1, lower average pain score during hospitalization, shorter duration of operation room use, less frequent use of supplemental pain medication, and similar risk of postoperative complication and analgesia-related adverse effects compared with TEA after matching.
Given early TEA discontinuation after MIS and ICNB's noninferior pain relief, preemptive ICNB can be an alternative for TEA in patients undergoing MIS.
微创外科(MIS)期间行胸段硬膜外镇痛(TEA)的必要性尚不清楚。我们研究了 MIS 与开胸手术中 TEA 的疗效,以及预防性肋间神经阻滞(ICNB)在 MIS 中是否不劣于 TEA。
我们研究了 2014 年至 2019 年间行肺切除术的 393 例患者,其中 242 例接受了 MIS,151 例接受了开胸手术,并接受了 TEA(MIS+TEA 组)或不接受 TEA(MIS 组);2019 年至 2020 年间行 MIS 并接受 ICNB 的 93 例患者。为了解决选择偏倚,我们对 70 例 TEA 患者和 70 例 ICNB 患者进行了倾向评分匹配。终点是住院期间的疼痛评分、术后并发症、手术室使用时间、与镇痛相关的不良反应以及辅助止痛药物的使用。
1/3 的 MIS+TEA 组患者在术后第 1 天或更早停止使用 TEA,而早期停止使用 TEA 的患者第二天疼痛更严重。与非 TEA 组相比,无论手术侵袭性如何,TEA 组的疼痛评分均较低,且开胸手术组的并发症风险较低,但 MIS 组则无此结果。对于 MIS,ICNB 在术后第 1 天的疼痛评分与 TEA 相当,住院期间的平均疼痛评分较低,手术室使用时间较短,辅助止痛药物的使用频率较低,且术后并发症和与镇痛相关的不良反应风险与 TEA 匹配后相当。
鉴于 MIS 后 TEA 早期停药以及 ICNB 的非劣效镇痛效果,预防性 ICNB 可作为 MIS 患者 TEA 的替代方法。